Netherlands, Utrecht (Utrecht City Campus)

Pharmacoepidemiology & Drug Safety

when 30 June 2014 - 4 July 2014
duration 1 week
fee EUR 1150

With the prospect that innovative drug therapies will be introduced in the coming years, society demands new approaches and concepts for comparative risk/benefit evaluation. Assessment of safety and risk management of different drug therapies is done in the framework of observational epidemiological studies (proof of 'safety', proof of 'effectiveness'). This is the logical next step after randomized clinical trials, which are designed to provide evidence of a drugs 'efficacy'.

Course leader

Dr. Olaf Klungel

Target group

(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge public health/medicine who have an interest in pharmacoepidemiology.

Course aim

Students will learn about the typical problems (e.g. confounding by indication, rare side effects) and approaches to deal with these problems in the practice of pharmacoepidemiology.

Credits info

Certificate of Attendance

Fee info

EUR 1150: • € 1150 - Course + course materials + housing
• € 950 - Course + course materials


Utrecht Summer School doesn't offer scholarships for this course.

Register for this course
on course website